Drugs News and Research

RSS

Much more needs to be done to tackle heart disease in South Asians in the United Kingdom

Health inequality between ethnic groups in the United Kingdom is widening. Death rates from coronary heart disease in South Asians (immigrants from India, Pakistan, Bangladesh, and Sri Lanka) have declined at a slower rate than in the indigenous population, while evidence shows that second and third generation South Asians seem to be displaying many of the same risk characteristics that make them prone to coronary heart disease as their parents and grandparents.

26 May 2005

Long pointed kitchen knives should be banned

Violent crime is on the increase in the UK, say the authors, whose experience of working in emergency departments suggests that kitchen knives are used in as many as half of all stabbings.

26 May 2005

Clinton Foundation aims to treat two million people with HIV in India by 2008

Former United States President Bill Clinton announced in India this week that his Foundation plans to train 150,000 private sector doctors for care and treatment.

26 May 2005

Scientists renew warnings over a bird flu pandemic

Scientists have again renewed their warnings about the potential global effect of a flu pandemic on health and economy.

26 May 2005

New type of inhalation chemotherapy

Pediatric cancer specialists at The Children's Hospital at Montefiore (CHAM) are investigating a new type of inhalation chemotherapy with the potential to treat children with a deadly bone cancer that has spread to their lungs.

26 May 2005

Increase in heart surgery mortality from SSRIs or depression?

Duke University Medical Center researchers have found that patients who were using a class of anti-depression drugs known as selective serotonin reuptake inhibitors (SSRI) prior to undergoing coronary artery bypass surgery have significantly higher death and rehospitalization rates up to five years after the procedure than patients who were not on SSRIs.

26 May 2005

Most serious side effects in statins may be higher in one of the newest drugs, rosuvastatin (Crestor)

A post-market analysis of cholesterol-lowering drugs called statins indicates that some of the most serious side effects may be higher in one of the newest drugs, rosuvastatin (Crestor). The drug is the strongest statin available because it has the greatest effect per milligram on low-density lipoprotein ("bad" cholesterol).

26 May 2005

'Brown fat cells' hold clues for possible obesity treatments

Joslin Diabetes Center scientists have discovered a group of genes that govern the genesis of calorie-burning fat cells. This discovery may lead to novel ways to treat obesity in humans.

26 May 2005

Study shows how COX-2 inhibitors lead to heart disease

University of Pennsylvania School of Medicine researchers have found additional evidence that may help explain how selective inhibitors of COX-2 might predispose individuals to heart disease and stroke.

26 May 2005

Tragic death of 5 year old asthma patient was avoidable and due to complacency of health professionals

At a fatal accident inquiry a sheriff has hit out at the "complacency" of health professionals and a drugs manufacturer over the safety of an asthma inhaler steroid.

25 May 2005

Statin drugs prescribed for heart disease also reduce the risk of colon cancer

According to new research released this week people taking statin drugs to control the progression of heart disease may be getting the extra benefit of protection from colorectal cancer.

25 May 2005

WIN compound - a prototype drug for curing colds - is showing so much promise

An antiviral compound that wiggles its way into the common cold virus may provide one piece of the solution to halting the infection, say Purdue University scientists.

25 May 2005

Protein TRPA1 essential for hearing also vital for pain perception

The same protein that "translates" sound into nerve signals to the brain and enables individuals to hear is also required for pain perception, researchers from Northwestern University Feinberg School of Medicine have found.

25 May 2005

Exercise boosts chances of surviving breast cancer

A new study is the first to produce evidence that exercise improves the prospects of beating a malignancy, and proves that being physically active boosts the odds that breast cancer patients will survive the disease.

25 May 2005

Pharmaceutical industry faces multiple challenges - future lies in drug pipeline sustainability

High clinical development costs coupled with declining drug discovery success rates are causing productivity levels to fall in the global pharmaceuticals industry. The imminent patent expiry of several major blockbuster drugs and the related rise of cheaper generic alternatives is further exacerbating the situation.

25 May 2005

Patients on hypertension and lipid-lowering medications not sticking to prescriptions

A new study designed to look at how well patients with high blood pressure and dyslipidemia (high cholesterol levels) coped with their medication, has discovered that within six months many patients fail to take blood pressure or cholesterol medication properly.

24 May 2005

Six deaths in transplant patients now linked to rodent virus

In the latest news on the subject, experts now believe they can link at least six deaths of organ transplant patients to a rodent virus, which raises questions about whether others may have gone undetected and whether the germ also could spread through blood transfusions.

24 May 2005

New cholesterol drug Crestor causes safety concerns

A study by a leading medical journal has concluded that AstraZeneca's controversial drug Crestor produces more than twice as many side effects as other common cholesterol lowering treatments.

24 May 2005

Obstructive sleep apnea significantly increases the risk of suffering a stroke

Moderate to severe cases of the nighttime breathing problem known as obstructive sleep apnea significantly increases the risk of suffering a stroke, according to a study to be presented at the American Thoracic Society International Conference on May 23.

23 May 2005

Within six months, one in three patients fail to take cardiovascular risk-lowering medications as prescribed

Therapy that includes medications to reduce high blood pressure and to lower lipid levels can reduce risk for heart disease, but within six months, more than a third of patients fail to take one or both medications as prescribed, according to a study in the May 23 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

23 May 2005